Sarecycline: a narrow spectrum tetracycline for the treatment of moderate-to-severe acne vulgaris

Sarecycline is a novel, narrow-spectrum, once-daily tetracycline-derived oral antibiotic that is FDA-approved in the US to be taken with or without food for moderate-to-severe acne vulgaris for ages 9 years of age and older. Sarecycline possesses anti-inflammatory properties and potent activity agai...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Angela Yen, Charles, Jean Elizze M, Moore, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802708/
https://www.ncbi.nlm.nih.gov/pubmed/31475868
http://dx.doi.org/10.2217/fmb-2019-0199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802708/
https://www.ncbi.nlm.nih.gov/pubmed/31475868
http://dx.doi.org/10.2217/fmb-2019-0199

Ejemplares similares